These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 13547140)
21. Trypanosoma brucei rhodesiense: effect of immunosuppression on the efficacy of melarsoprol treatment of infected mice. Frommel TO Exp Parasitol; 1988 Dec; 67(2):364-6. PubMed ID: 3191962 [No Abstract] [Full Text] [Related]
22. Mel B in the treatment of tryparsamide resistant T. gambiense sleeping sickness: observations on drug resistance in the trypanosomes of the French Cameroun. FRIEDHEIM EA Am J Trop Med Hyg; 1951 Mar; 31(2):218-35. PubMed ID: 14819516 [No Abstract] [Full Text] [Related]
23. [Practical value of the complement fixation reaction in trypanosomiasis gambiense. II. Complement fixation reaction in a case of relapse after medicinal treatment]. EVENS F; SCHOENAERS F; NEUJEAN G; KAECKENBEEK A; STYNS J Ann Soc Belg Med Trop (1920); 1953 Oct; 33(5):389-402. PubMed ID: 13139073 [No Abstract] [Full Text] [Related]
24. [Arsenical-induced encephalopathy during the treatment of African trypanosomiasis. Apropos of a case with a favorable outcome]. Pialoux G; Kernbaum S; Vachon F Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):555-6. PubMed ID: 3197251 [TBL] [Abstract][Full Text] [Related]
25. The treatment of T. rhodesiense sleeping sickness, with special reference to its physio-pathological and epidemiological basis. Buyst H Ann Soc Belg Med Trop; 1975; 55(2):95-104. PubMed ID: 1164053 [No Abstract] [Full Text] [Related]
26. Nitrofurazone in the treatment of sleeping sickness due to Trypanosoma rhodesiense. APTED FI Trans R Soc Trop Med Hyg; 1960 May; 54():225-8. PubMed ID: 13793989 [No Abstract] [Full Text] [Related]
27. The value of drugs commonly used in the treatment of T. rhodesiense sleeping sickness. SILVA MA An Inst Med Trop (Lisb); 1957; 14(1-2):159-70. PubMed ID: 13521347 [No Abstract] [Full Text] [Related]
28. [Metronidazole in a case of sleeping sickness caused by Trypanosoma rhodesiense]. ADRIAENSSENS K Ann Soc Belg Med Trop (1920); 1961 Oct; 41():393-5. PubMed ID: 13859472 [No Abstract] [Full Text] [Related]
29. [Treatment of human African trypanosomiasis]. Dumas M; Breton JC; Pestre-Alexandre M; Nicolas JA; Catanzano G Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):622-7. PubMed ID: 6673855 [TBL] [Abstract][Full Text] [Related]
30. [Arsenical resistance and difluoromethylornithine in the treatment of human African trypanosomiasis]. Kazyumba GL; Ruppol JF; Tshefu AK; Nkanga N Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):591-4. PubMed ID: 3143492 [TBL] [Abstract][Full Text] [Related]
31. [African trypanosomiasis at the Claude-Bernard Hospital (diagnostic circumstances and therapeutic problems)]. Coulaud JP; Vachon F; Lebigot P; Lagarde P; Pasticier A; Saimot G Ann Med Interne (Paris); 1975; 126(8-9):671-6. PubMed ID: 1217776 [No Abstract] [Full Text] [Related]
32. Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya. Bales JD; Harrison SM; Mbwabi DL; Schecter PJ Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():111-4. PubMed ID: 2515816 [TBL] [Abstract][Full Text] [Related]
33. Trypanosomiasis in a rural hospital in Tanzania. A retrospective study of its management and the results of treatment. Veeken HJ; Ebeling MC; Dolmans WM Trop Geogr Med; 1989 Apr; 41(2):113-7. PubMed ID: 2763355 [TBL] [Abstract][Full Text] [Related]
34. [New contribution on arsobal (R.P. 3854) therapy of trypanosomiasis; its effectiveness in former trypanosomiasis patients, with meningoencephalitis, resistant to trypanocides customarily used]. CECCALDI J Bull Soc Pathol Exot Filiales; 1953; 46(1):95-121. PubMed ID: 13066959 [No Abstract] [Full Text] [Related]
35. Melarsoprol and reactive encephalopathy in Trypanosoma brucei rhodesiense. Arroz JO Trans R Soc Trop Med Hyg; 1987; 81(2):192. PubMed ID: 3617176 [No Abstract] [Full Text] [Related]
36. A TRIAL OF MEL W IN THE TREATMENT OF TRYPANOSOMA RHODESIENSE SLEEPING SICKNESS. ROBERTSON DH Trans R Soc Trop Med Hyg; 1963 Jul; 57():274-89. PubMed ID: 14047025 [No Abstract] [Full Text] [Related]
37. Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals. Yarlett N; Goldberg B; Nathan HC; Garofalo J; Bacchi CJ Exp Parasitol; 1991 Feb; 72(2):205-15. PubMed ID: 1849084 [TBL] [Abstract][Full Text] [Related]
38. [EEG and treatment with Arsobal in human African trypanosomiasis]. Giordano C; Boa FY; Kouassi B; Piquemal M; Akani F; Yapi P; Sonan T Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):482-3. PubMed ID: 3197245 [TBL] [Abstract][Full Text] [Related]
39. Experimental infection of goats with Trypanosoma brucei ssp. and effects of treatment with suramin and Mel-B. Wellde BT; Reardon MJ; Chumo DA; Muriithi RM; Towett S; Mwangi J Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():161-9. PubMed ID: 2619390 [TBL] [Abstract][Full Text] [Related]
40. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study. Poltera AA; Hochmann A; Lambert PH Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]